The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Global Cancer Incidence and Mortality Rates and Trends—An UpdateCancer Epidemiology, Biomarkers & Prevention, 2016
- Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignanciesBritish Journal of Surgery, 2015
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexJournal of Clinical Oncology, 2013
- Frailty as a Predictor of Surgical Outcomes in Older PatientsJournal of the American College of Surgeons, 2010
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Expanding Criteria for Resectability of Colorectal Liver MetastasesThe Oncologist, 2008
- Surgical Therapy for Colorectal Metastases to the LiverJournal of Gastrointestinal Surgery, 2007
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical DisabilityJournal of the American Geriatrics Society, 2002